Amber ListRecovering

USOUnited States Oil Fund

-29.4%
from rolling 252-day high of $154.08 set 2026-05-18 · 53d ago
Current
$108.70
Decline depth
-29.4%
Decline σ
7.9σ
TFC
0/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$USO landed on the list 2026-06-16, down 25.1% from its 52-week high that day — now down -29.4%.

That's 4.4 percentage points deeper than the day it joined. It bottomed 33.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-06-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

USO qualifies for the Amber List on decline depth.

Decline depth
-29.4%
From rolling 252-day high of $154.08, 53d ago. Past the 20% Watch threshold.
Time-frame continuity
0/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
7.9σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.64% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about USO.

USO qualifies for the Amber List on decline depth — down -29.4% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 7.9σ over 20 bars.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether USO's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: moderate alignment, current phase weekly. Last bar types — daily 2D (red), weekly 2U (green), monthly 2D (green).

52-week range

52W low $65.99 48.5% of range 52W high $154.08

Questions about USO

What people ask.

Why is USO on Broken Stocks?

USO qualifies for the Amber List on decline depth. It is down -29.4% from its rolling 252-day high of $154.08, set on 2026-05-18 — 53d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for USO?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — USO is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is USO a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. USO is down -29.4% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is USO a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is USO trading inside its 52-week range?

At $108.70, USO sits 48.5% of the way from its 52-week low ($65.99) to its 52-week high ($154.08). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has USO been declining?

The current 29.4% decline accrued over 53d, which annualizes to roughly -202.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.